Monday, June 14th
- This week started with the addition of five individuals to the France list of sanctions pursuant to the France Anti-Terrorism program. (Here)
Tuesday, June 15th - Four individuals came off the France list of sanctions as their six-month designation period expired.
- The U.S. Department of State uses the authority granted under Section 7031(c) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2021 to impose travel bans (a type of sanction) more frequently. On Tuesday, two former Namibian government officials (and two of their family members) were publicly designated, due to their involvement in significant corruption. (Here)
Wednesday, June 16th
- France added eight individuals to the France list of sanctions pursuant to the France Anti-Terrorism program. (Here)
Thursday, June 17th
- OFSI made two of its webinars about licensing available through August 16th. (Here)
- The U.S. Department of State designated a Guatemalan Congressperson and three of his family members under Section 7031(c) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2021. (Here)
- OFAC issued three General Licenses authorizing a range of covid relief-related transactions that were otherwise prohibited pursuant to Iran, Syria, and Venezuela programs. (Here) For more details, check out this Client Alert prepared by Akrivis Law Group.
Friday, June 18th
- The Security Council added an individual to its ISIL (Da’esh) and Al-Qaida Sanctions List of individuals and entities subject to the assets freeze, travel ban and arms embargo. (Here)
- France added nine individuals to its list of sanctions targets pursuant to the country's Anti-Terrorism sanctions. (Here)
Recommendation of the week
- This week's recommendation is a D.C. District Court's opinion which dismissed Oleg Deripaska's challenge to the sanctions imposed against him by the United States. It is a reminder that challenging OFAC is not an easy task. (Here)
To get your weekly alerts please click here.